HRMY
Harmony Biosciences Holdings, Inc. · Healthcare · Biotechnology
动量输入(同类管理人):
持有人广度 -5.6% ·
股份流向 -0.8% ·
净新建仓位 -5.9%
· 公式
广泛减持:持股数量下降,持有人数量减少
所有持股数据:仅限已追踪的 13F 管理人,普通股持仓,报告期 Q2 2025
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 21.01K | $831,838 | n/a | −1 |
| Q2 2026 | 111 | +5 | 37.63M | $1.37B | +12 | −8 |
| Q1 2026 | 110 | -3 | 39.20M | $1.10B | +5 | −9 |
| Q4 2025 | 114 | +1 | 39.01M | $1.46B | +2 | n/a |
| Q3 2025 | 20 | +1 | 24.69M | $680.58M | +2 | −2 |
| Q2 2025 | 17 | -1 | 23.07M | $729.13M | +1 | −2 |
| Q1 2025 | 15 | +1 | 6.74M | $223.55M | +1 | n/a |
| Q4 2024 | 14 | -1 | 7.61M | $261.77M | n/a | −1 |
| Q3 2024 | 14 | +1 | 3.56M | $142.57M | +1 | n/a |
| Q2 2024 | 13 | n/a | 3.50M | $105.70M | n/a | n/a |
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 6.74M | n/a | $212.89M | 0.0% | n/c | 1 | SEC ↗ ×15 |
| 2 | The Vanguard Group ✦ (被动) | 5.11M | n/a | $161.50M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | Fidelity (FMR) ✦ | 4.69M | n/a | $148.15M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 4 | State Street Global Advisors ✦ (被动) | 1.63M | +3.2% | $51.48M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Marshall Wace ✦ | 1.21M | +36.3% | $38.22M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 6 | Geode Capital Management ✦ (被动) | 1.05M | +9.2% | $33.32M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 7 | Renaissance Technologies ✦ | 929.47K | +10.6% | $29.37M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 8 | Arrowstreet Capital ✦ | 906.91K | +127.6% | $28.66M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | D. E. Shaw & Co. ✦ | 252.98K | -20.9% | $7.99M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 10 | Two Sigma Investments ✦ | 238.89K | -30.9% | $7.55M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 152.03K | -8.6% | $4.80M | 0.0% | ▼ Trim | 5 | SEC ↗ ×5 |
| 12 | Gotham Asset Management ✦ | 39.71K | +71.4% | $1.25M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 34.83K | +16.7% | $1.10M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 14 | Point72 Asset Management ✦ | 33.78K | 新增 | $1.07M | 0.0% | New | 1 | SEC ↗ |
| 15 | Millennium Management ✦ | 29.29K | -62.7% | $925,532 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 16 | Wellington Management ✦ | 15.73K | -3.8% | $497,131 | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
| 17 | Norges Bank ✦ (被动) | 11.12K | -79.4% | $351,487 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例,即持仓信心指标。✦ = 精选管理人。
新增买入方
| Point72 Asset Management | $1.07M | 0.0% |
已清仓
| Citadel Advisors | $28.62M | 曾为 0.0% |
| Adage Capital Partners | $5.58M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构(SEC结构化数据, Q1 2026): 306 持有人, 54.70M 股份, $1.38B 已申报. 这是与上方被追踪全域数据不同的较早期间,两者从不混用。
持有该证券的受追踪机构最常同时持有的其他证券:基于共同持有计数,而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Officer · 35.85K 股 · $1.54M
Officer · 800 股 · $34,400
Officer · 1.80K 股 · $77,426
Officer · 22.95K 股 · $989,350
Officer · 1.00K 股 · $42,795
Officer · 4.50K 股 · $190,114
Officer · 5.50K 股 · $230,911
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论